Canine Adenovirus Antibody Rapid Test Diagnosis of Adenovirus

• Type: Detection Card
• Syringe: None
• Blood Sampling Needle: None
• Breathing Pattern: None
• Animal Anesthesia Machine Control Method: None
• Assay Time: 5-10 Minutes
• Model NO.: JCA042D
• Storage Temperature: 2-30 Degree
• Payment: T/T, Western Union, Paypal
• Customized: Accpet
• Transport Package: Carton
• Specification: 10Tests/Kit
• Trademark: PETX
• Origin: Hangzhou
• HS Code: 38220010
• Production Capacity: 5000000PCS/Year

Product Description

Canine Adenovirus Antibody Rapid Test diagnosis of adenovirus

 

Principle	Immunochromatographic assay
Intended use	Veterinary in vitro diagnostic 1) Auxiliary diagnosis on Canine infection for veterinarians in practice. 2) Precautionary diagnosis for home use, point-of-care and early judgement for pet owners.  3) Study use for researchers.
Detection time	5 to 10 minutes
Specime	serum or plasma
Storage	4 to 30 degree centigrade
Shelf life	24 months
Package	10 rapid tests  10 sterile swabs 10 assay buffer 1 package insert
Advantages	1) Good sensitivity and specificity 2) Strong R&D and technical support 3) Stable performance.  4) Friendly to end users
Relative products	- Canine CPV-CCV Combo Test - Giardia Antigen Test

INTENDED USE

The Infectious Canine Hepatitis Antigen Rapid Test is a lateral flow immunochromatographic assay for the qualitative detection of Canine Adenovirus type-I antigen (CAV-I Ag) in secretions from dog's eyes, nasal cavities, and anus or in serum, plasma specimen. 
Assay Time:  5-10 minutes

PRINCIPLE
The Infectious Canine Hepatitis Antigen Rapid Test is based on sandwich lateral flow immunochromatographic assay. The test device has a testing window for the observation of assay running and result reading. The testing window has an invisible T (test) zone and a C (control) zone before running the assay. When the treated sample was applied into the sample hole on the device, the liquid will laterally flow through the surface of the test strip and react with the pre-coated monoclonal antibodies. If there is CAV-I antigen in the specimen, a visible T line will appears. The C line should always appear after a sample is applied, which indicates a valid result. By this means, the device can accurately indicate the presence of CAV-I virus antigen in the specimen.

TEST PROCEDURE

• Collect dog's ocular, nasal or anus secretions with the cotton swab and make the swab wet sufficiently.
• Insert the swab into the provided assay buffer tube. Agitates it to get efficient sample extraction. 
• Take out the test device from the foil pouch and place it horizontally.
• Suck the treated sample extraction from the assay buffer tube and place 3 drops into the sample hole "S" of the test device.
• Interpret the result in 5-10 minutes. Result after 10 minutes is considered as invalid
• 

COMPANY INTRODUCTION

J&G Biotech Ltd is a privately held company located in London, England. J&G Biotech Ltd and its corporates are engaged in the manufacturing and distribution of in vitro diagnostic products for companion animals, livestock, as well as rapid screening food safety test kits for veterinary drug residues, mycotoxins, and food-borne pathogens. The companion animal rapid test kits have a worldwide distribution under the brand PetX. Some innovative immunoassays are developed to work with reader machines for better service to veterinary practitioners.

PRODUCT LIST


IF ANY INQUIRY, PLEASE CONTACT AT:

Company Profile

Hangzhou Immuno Biotech Co., Ltd is the original organization in IMMNUO Group, which was established in 2014. The team of Hangzhou Immuno Biotech has developed a series of proteins and rapid test kits for the in vitro diagnostic industry in early stage. Gradually, IMMUNO was well known as a good R&D partner and good supplier of veterinary rapid test products. With great patience and continuous investment in design and development of IVD relative reagents and test kits, we got several encouraging achievements in the past year, especially in veterinary diagnostic field.

IMMUNO has participated in the fighting with the epidemic and made a contribution. With a deep reflection, IMMUNO has realized the possibility of potential pandemic of zoonosis in future between human beings and animals. Diseases between human and animal are important projects what we are familiar with and then we decided to persue the "One Health" philosophy from then on.

To achieve that goal, IMMUNO has decided to focus on the development of rapid testing tools for zoonosis diseases and formed a joint action within our group. Now, we have a scientific team to analyse and develop recombinant proteins and antibodies, a technical team to apply the proteins and antibodies to immunoassay format, and also a joint team to study the diseases themselves and their possible application scenarios.

Hangzhou Immuno Biotech Co., Ltd. will focus on the human medical diagnostic field and mainly cover the following directions: rapid tests for vector-borne diseases(VBDs), rapid tests for sexually transmitted diseases (STDs), rapid tests for respiratory system diseases and rapid tests for digestive system diseases. Besides, with strong R&D capability, we would pay more attention to the diagnosis of neglected tropical diseases (NTDs).

IMMUNO will continuously contribute to the development of diagnostic tools for the whole human society and nature world.